Blood neoplasia
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.
Reid W Merryman, Justin Kline, Robert A Redd, Harrison Olszewski, Emma Welsh, Kathleen Pfaff, Hannah Lee, Mikaela McDonough, Inhye E Ahn, Jennifer R Brown, Jennifer L Crombie, Matthew S Davids, David C Fisher, Eric D Jacobsen, Caron A Jacobson
Published: 202610.1016/j.bneo.2025.100173
No abstract available for this study.